MONTREAL, July 11 - Neptune Technologies & Bioressources Inc. finalizes a conclusive Phase II clinical trial on the effects of Neptune Krill Oil (NKO) on premenstrual syndrome (PMS).
The Editorial Staff & Review Board of Alternative Medicine Review has published in the May 2003 issue, as Original Research, the study titled "Evaluation of the Effects of Neptune Krill Oil on the Management of Premenstrual Syndrome and Dysmenorrhea."
Alternative Medicine Review, one of the most recognized peer-reviewed publications in the industry, provides accurate and clinically relevant articles, reviews and abstracts. Published by Thorne Research, it is in its eighth year of publication and is indexed in the most accredited medical directories & databases like Medline, Embase, Cinahl and Index Medicus. More than 8,000 copies per month are distributed to medical doctors, health care practitioners, pharmacies and medical libraries in USA, New Zealand, Australia and Europe.
According to the article published, "The final results of the present study suggest within high levels of confidence that NKO can significantly reduce both the physical and emotional symptoms related to premenstrual syndrome, and is significantly more effective for the management of dysmenorrhea as well as all emotional premenstrual symptoms than fish oil. NKO has a unique biomolecular profile of phospholipids, Omega-3 fatty acids, and diverse antioxidants that surpasses the usual profile of fish oil."
"We are very proud that the results of our study have been successfully reviewed and accepted by the highly recognized physicians of the Alternative Medicine Review medical journal, the most accredited peer-reviewed journal on clinical therapeutics. It is estimated that the life of 85-97% of women of reproductive age is strongly disrupted by PMS. Doctors have resorted to antidepressants to treat their patients for PMS. Finally, NKO offers a safe and natural alternative choice, without the side effects of drugs and brings many other health benefits" comments Dr. Tina Sampalis, Vice-President of Research & Development at Neptune Technologies & Bioressources Inc.
Neptune Technologies & Bioressources Inc. develops and exploits marine biomasses with its extraction processes utilizing marine biomasses such as krill and other underexploited marine resources such as red crab and calanus. The company is industrializing its extraction process "Neptune OceanExtract" in order to offer its products to nutraceutical, cosmetic, cosmeceutical and biopharmaceutical markets.
Due to its technologies, Neptune Technologies & Bioressources Inc. is strategically well positioned in the huge and emerging markets based on the health and wellness concepts, markets in which natural biomass extraction will play an important role in developing nutrigenomics, the next wave in nutritional research.
Neptune Technologies & Bioressources Inc. is listed on the TSX-V Venture Exchange where its shares trade under the ticker symbol NTB. This transaction is therefore subject to its approval.